Google
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: COVID-19 Vaccines
News is evolving rapidly about COVID-19 and COVID-19 vaccines. Early results from the COVID-19 vaccine trials are very promising, although the true benefits and risks will not be known until a larger number of people receive the vaccine.
The Centers for Disease Control and Prevention (CDC) lists sickle cell disease (SCD) as one of the populations vulnerable to severe COVID-19. Sickle cell disease raises the risk for serious problems with COVID-19, especially when compared to the same age in the general population.
+myBinderRelated Content
-
Sickle Cell Disease and COVID-19: An Outline to Decrease Burden and Minimize Morbidity (Adapted for Sub-Saharan Afri...April 1, 2020- Sickle cell disease (SCD)...
-
COVID-19 Resources for Non-Profit Leaders and the Community | National Organization for Rare DisordersThe health and safety of those with rare...
-
Patricia Frieson was more than the 1st COVID-19 death in Illinois. She was their sister.When she was 11, her parents, Dan and Ef...
-
Sickle Cell + COVID-19 + Mental Health | The Sickle Cell PodcastThe Sickle Cell Podcast is an effort by ...
-
COVID-19: Highest Risk Patients are Asked to Stay at Home for 12 Weeks [England]A million and a half people in England w...
-
Coronavirus/COVID-19 & Sickle Cell Disorder (Sickle Cell Foundation Nigeria)What is Coronavirus? -It is a new virus...
-
FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDS) for COVID-19[3/19/2020] FDA is aware of news reports...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.